Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Zimmer Biomet
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
38.0%
+2.1% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:NeutralThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Smith & Nephew plc
Competitor Displacement Rate
22.0%
Competitors are displacing Zimmer Biomet in 22.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Zimmer Biomet competes with Smith & Nephew's advanced robotic surgery platforms and comprehensive implant solutions. Competitors are perceived as having more cutting-edge technology.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[stryker.com][depuy.com]⚠️ Identified Vulnerability:Robotic Surgery
Primary Threat Identified:Smith & Nephew plc
Target Persona:Orthopedic Surgeons
🚨 Threat Velocity:7/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)